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Abstract
Background: With the recent growth of information on sequence variations in the human genome, predictions regarding
the functional effects and relevance to disease phenotypes of coding sequence variations are becoming increasingly
important. The aims of this study were to catalog protein-coding sequence variations (CVs) occurring in genetic variation
databases and to use bioinformatic programs to analyze CVs. In addition, we aim to provide insight into the functionality of
the reference databases.
Methodology and Findings: To catalog CVs on a genome-wide scale with regard to protein function and disease, we
investigated three representative databases; the Human Gene Mutation Database (HGMD), the Single Nucleotide
Polymorphisms database (dbSNP), and the Haplotype Map (HapMap). Using these three databases, we analyzed CVs at the
protein function level with bioinformatic programs. We proposed a combinatorial approach using the Support Vector Machine
(SVM) to increase the performance of the prediction programs. By cataloging the coding sequence variations using these
databases, we found that 4.36% of CVs from HGMD are concurrently registered in dbSNP (8.11% of CVs from dbSNP are
concurrent in HGMD). The pattern of substitutions and functional consequences predicted by three bioinformatic programswas
significantly different among concurrent CVs, and CVs occurring solely in HGMD or in dbSNP. The experimental results showed
that the proposed SVM combination noticeably outperformed the individual prediction programs.
Conclusions: This is the first study to compare human sequence variations in HGMD, dbSNP and HapMap at the genome-
wide level. We found that a significant proportion of CVs in HGMD and dbSNP overlap, and we emphasize the need to use
caution when interpreting the phenotypic relevance of these concurrent CVs. Combining bioinformatic programs can be
helpful in predicting the functional consequences of CVs because it improved the performance of functional predictions.
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Introduction
Unprecedented advancements in molecular technology and
major initiatives such as the Human Genome Project and the
International Haplotype Map Project have created a need for
methods to interpret the myriad sequence variations in the human
genome, and to catalog disease-causing mutations. This has led to
the question of how to systematically collect and curate the
variation data [1]. In addition, progress in sequencing technology
has allowed mutational analysis of more than 10,000 genes in a
single individual and has accelerated research on disease-
associated allelic variations at the whole genome sequencing level
[2]. The human genome is estimated to have up to 200,000 amino
acid-substituting variations in the protein-coding sequences (CVs),
also called nonsynonymous single nucleotide polymorphisms
(nsSNPs) [3]. While substituting CVs may contribute to phenotype
differences among individuals such as hair color, skin color [4,5]
and disease susceptibility [6–9], certain CVs (generally missense
mutations) are known to cause highly-penetrant, Mendelian-
inherited pathological conditions. Missense mutations account for
approximately half of all allelic variants underlying inherited
human diseases [10,11]. As a result, it is vital that we correlate and
attribute specific phenotypes to certain CVs. Database searches
and bioinformatic analyses are the primary tools for this purpose.
The three most representative databases are Human Gene
Mutation Database (HGMD), Single Nucleotide Polymorphisms
database (dbSNP), and Haplotype Map (HapMap). Each database
has been developed with different features, for different purposes.
Several studies have investigated CVs with regard to human
disease phenotypes; however, they most commonly involved a
limited number of genes, such as those related to familial cancer
syndromes [12,13]. Since no studies have investigated genome-wide
CVs in different reference databases, we cataloged CVs that occur in
both HGMD and dbSNP, and characterized concurrent CVs using
bioinformatics to provide unique insight into the optimal uses of
those databases. We first prepared three different datasets of CVs
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extracted from HGMD, dbSNP, and HapMap (defined as CVM,
CVS, and CVH, respectively). We then analyzed how the three
datasets overlap, and characterized the CVs according to the
patterns of amino acid substitutions. In addition, we performed
functional predictions of CVs using selected in silico algorithms as well
as a combinatorial approach that we developed using the Support
Vector Machine (SVM). We found that combination improved the
prediction performance of individual algorithms.
Results
Coding Sequence Variations Concurrent in dbSNP and
HGMD
A total of 74,784 CVs from 9513 genes were retrieved from the
dbSNP database (CVS). A total of 26,037 CVs from 1477 genes
were retrieved from the HGMD database (CVM) (Table 1). The
average number of CVs per gene in dbSNP and HGMD was 7.9
and 17.6, respectively. The two datasets were then matched in a
gene-specific manner to find CVs concurrent in the two databases.
First, we obtained a list of 1069 genes that had sequence variation
information in both dbSNP and HGMD. These ‘matched genes’
totaled 12,399 CVS (group [S] in Figure 1) and 23,045 CVM
(group [M] in Figure 1). Among them, 1005 variations occurred
both in dbSNP and in HGMD (‘concurrent’ CVs, group [C] in
Figure 1; the complete list is in Table S1). In summary, 8.11%
(1005/12,399) of the CVs from dbSNP are registered as CVM in
HGMD, and 4.36% (1005/23,045) from HGMD were registered
as CVS in dbSNP. We also made a subset of polymorphisms from
a set of 12,399 CVS (group [S]) by a batch query to the HapMap
dataset. As a result, we obtained a subset of 4414 CVH (group
[H]), and a resultant subset of CVs that were concurrent in
HapMap and in HGMD (group [Ch] in Figure 1).
Detailed distributions of CVs in the matched genes were analyzed
and the resultant concurrent CVs sorted according to the type of
variation (Table 2). Among the 12,399 CVS, nsSNPs accounted for
the largest proportion (6809/12,399; 54.9%), followed by synony-
mous SNPs (snSNPs) (5416/12,399; 43.7%) and truncating SNPs
(trSNPs) (174/12,399; 1.40%). The distribution was similar in the
HapMap dataset (52.1%, 46.9%, and 1.02% for nsSNPs, snSNPs,
and trSNPs, respectively). Among the 23,045 CVM, missense
mutations accounted for the largest proportion (17,970/23,045;
78.0%), followed by nonsense mutations (5006/23,045; 21.7%). In a
very small proportion of CVM (69/23,045; 0.299%), a nucleotide
substitution was expected to retain the original amino acid, instead of
changing it to another amino acid or stop codon. Among the
concurrent CVs (group [C]), amino acid-substituting (AA1.AA2)
CVs were by far the most common (934/1005; 92.9%). Truncation
variations accounted for 4.08% (41/1005), followed by variations
expected to retain the original amino acid (30/1005; 2.99%). When
CVH were taken into consideration, the proportion of amino acid-
substituting CVs was almost unchanged (302/332; 91.0%). The
proportion of the AA1.AA1 group (20/332; 6.02%) was higher
than that of truncation variations (10/332; 3.01%). We observed
that variations in three different categories in the concurrent CVs
(group [C]) showed different distributions of SNP validation
scores calculated from frequency information, submitter’s validation
and availability in HapMap (Validation status code is available
at ftp://ftp.ncbi.nih.gov/snp/database/organism_shared_data/
SnpValidationCode.bcp.gz) (Figure S1). The average of trSNPs
validation scores was the lowest at 1.27, followed by the nsSNPs at
2.03. The snSNPs average was the highest at 6.40. Among the 41
trSNPs, validation scores of 33 variations (80.5%) were less than 3,
while among the 30 snSNPs, validation scores of 23 variations
(76.7%) were greater than or equal to 3. The percent of variations
of validation score greater than 9 was 7.32% (3/41) for the trSNPs
and 35.5% (11/31) for the snSNPs. These results indicate that most
trSNPs in dbSNP were relatively less validated when compared to
snSNPs in dbSNP.
Since the issue of distinction between neutral and damaging
variations is frequently addressed for cancer-predisposing genes,
we focused our analyses on 86 genes associated with well-known
hereditary cancer syndromes [14] among the 1069 matched genes.
We found that 29 genes (33.7%) had at least one concurrent CV
(Table S2). The total number of concurrent CVs encountered in
those 29 genes was 141, which accounted for 14.0% of the total
concurrent CVs (Table S3). The largest number of concurrent
CVs was observed in the VHL gene (von Hippel-Lindau syndrome,
MIM# 193300), followed by BRCA1/BRCA2 (hereditary breast
cancer syndrome, MIM# 113705, 600185). The number of
nsSNPs was greater than that of missense mutations in four genes
(FANCC, WRN, PMS2, and CDK4).
Pattern of Amino Acid Substitutions According to Amino
Acid Group
We analyzed the pattern of amino acid substitutions in three
disjointed groups of variations, [S-C], [M-C], and [C], according
Figure 1. Comparison of variations of three databases. From the
1069 genes that have information on allelic variations both in dbSNPs
and HGMD, a total of 12,399 CVS (group [S]) and 23,045 CVM (group
[M]) are shown. Variations found in both dbSNP and HGMD are labeled
‘concurrent’ (group [C]). Variations occurring only in dbSNP or HGMD
(mutually exclusive occurrence) are labeled [S-C] and [M-C], respective-
ly. nsSNPs found in the HapMap database are labeled [H], and the
concurrent group [C] is subdivided into [Ch] (in HGMD and in HapMap)
and [C-Ch] (in HGMD and in dbSNP but not in HapMap).
doi:10.1371/journal.pone.0003575.g001
Table 1. Results of matching the SNP and mutation datasets.
Statistics dbSNP HGMD
No. of total genes 9513 1477
No. of total single base
substitution variations
74,784 26,037
No. of matched genes 1069
No. of variations of matched
genes
12,399 23,045
No. of concurrent variations 1005
Proportion of concurrent
variations
8.11% (1005/12,399) 4.36% (1005/23,045)
doi:10.1371/journal.pone.0003575.t001
Coding Variations in Humans
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to five amino acid groups (G1, nonpolar, aliphatic R group; G2,
aromatic R group; G3, polar, uncharged R group; G4, positively
charged R group; and G5, negatively charged R group). The most
striking difference between groups [S-C] and [M-C] was observed
in amino acid substitutions from the aromatic R group (G2) to the
polar, uncharged R group (G3) (1.9% vs 4.1%; see Figure 2). In
addition, substitutions from the polar, uncharged R group (G3) to
the aromatic R group (G2) were observed more often in group [M-
C] than in group [S-C] (4.7% vs 2.0%). To measure the difference
between the two types of variations, we calculated the chi-squared
values with degrees of freedom=1. A significant difference was
found (X2 = 143.8, P,3.9610233) between group [S-C] and group
[M-C] in the frequency of G2-G3 substitutions. This result
suggests the transition of amino acids between G2 and G3 could
potentially exert deleterious effects on protein function. Differenc-
es in the frequency of G2-G4 and G1-G4 substitutions were
notably high (X2 = 39.7, P,3.0610210 and X2 = 102.2,
P,5.2610224, respectively). In contrast, amino acid substitutions
between G3 and G5 occurred in group [S-C] slightly more often
than in group [M-C] (3.4% vs 2.3%). Remarkably, in all amino
acid groups, substitutions within the same amino acid group were
more frequently observed in group [S-C] than in group [M-C].
We have summarized these results in Table 3, based on two types
of amino acid substitutions—those within the same amino acid
group and those between different groups. The proportion of
amino acid substitutions within the same group in group [S-C] was
larger than in group [M-C] (38.0% vs 26.6%). For example, the
frequency of substitutions from valine to isoleucine in the
nonpolar, aliphatic R group was 2.4% in group [S-C], but 0.6%
in group [M-C]. Similarly, the frequency of substitutions from
isoleucine to valine in the nonpolar, aliphatic R group was 1.8% in
group [S-C], while it was 0.4% in group [M-C]. This finding
indicates that an amino acid substitution in an nsSNP may be less
likely to change the function of a protein. Substitutions within the
same amino acid group accounted for 30.8% of the concurrent
variants (group [C]), which falls between those in group [S-C] and
in group [M-C] (Table 3). The pattern of amino acid substitutions
in group [S-C] was significantly different from that in group [M-
C] (X2 = 417.3, P,9.5610293), which might reflect the different
underlying mutagenic mechanisms that create the variations in
these two groups. The pattern showed a significant difference
between group [C] and group [M-C] (X2 = 203.8, P,3.1610246),
than between group [C] and group [S-C] (X2 = 17.7,
P,2.661025).
Functional Prediction of Amino Acid-Substituting
Variations by Different In Silico Tools
Efforts have been made to develop algorithms for the prediction
of functional impact of a known or novel amino acid-substituting
variation without experimental characterization [15–22]. For the
functional prediction of amino acid-substituting CVs, which
accounted for the largest number of variations both in dbSNP
(nsSNPs) and in HGMD (missense mutations), as well as in the
group of concurrent variations (group [C] and [Ch]), we employed
three widely-used prediction programs—Sorting Intolerant From
Tolerant (SIFT) [18], Polymorphism Phenotyping (PolyPhen) [19]
and Protein Analysis Through Evolutionary Relationships (PAN-
THER) [21]. Two datasets were used, a set of 5875 nsSNPs in
group [S-C] (6809 minus 934) from dbSNP, and a set of 17,036
missense mutations in group [M-C] (17,970 minus 934) from
HGMD (Figure 1 and Table 2). We also used nsSNPs in HapMap
(group [H-Ch]), since HapMap is generally regarded to contain
neutral or less penetrant variations than dbSNP. SIFT and
PANTHER give results in two prediction categories—tolerated or
deleterious effects, while PolyPhen gives results in three catego-
ries—benign (probably lacking any phenotypic effect), possibly
damaging, and probably damaging (should affect protein function)
[19]. Prediction results are given as unknown when the reference
data are insufficient. We excluded variations with ambiguous
prediction results from the analyses.
From theHapMap dataset (group [H-Ch]), PANTHER and SIFT
predicted that 72.2% and 69.8% of the tested nsSNPs, respectively,
would be tolerated, and PolyPhen predicted 66.3% of the tested
nsSNPs to be benign (Table 4). The prediction results for nsSNPs
from dbSNP (group [S-C]) were slightly different from those for
nsSNPs from HapMap (group [H-Ch]). The proportion of nsSNPs
from dbSNP predicted to be deleterious was larger than that of
nsSNPs from HapMap (36.3% vs 30.2% for the SIFT prediction
results and 33.7% vs 27.8% for the PANTHER prediction results).
Likewise, the proportion of nsSNPs from dbSNP predicted to be
damaging by Polyphen was larger than that of nsSNPs from
HapMap (36.9% vs 33.7%).When we analyzed the damaging effects
predicted by PolyPhen, the proportion of variations predicted to be
‘possibly’ damaging was larger than that predicted to be ‘probably’
damaging in the HapMap dataset (19.1% vs 14.6%), while the
proportions were almost the same in the dbSNP dataset (18.0% vs
18.9%). In the HGMD dataset, the majority of missense mutations
were predicted to be deleterious by SIFT (65.2%) and PANTHER
(70.6%), and to be damaging by Polyphen (73.6%). In addition, the
Table 2. Single amino acid-substituting variations and distribution of concurrent variations in dbSNP/HapMap and HGMD by type
of variation.
Type of variation AA1.AA2a AA1.TRb AA1.AA1c Total Figure 1d
dbSNP (No./%) 6809 (54.9) 174 (1.40) 5416 (43.7) 12,399 (100) S
HapMap (No./%) 2299 (52.1) 45 (1.02) 2070 (46.9) 4414 (100) H
HGMD (No./%) 17,970 (78.0) 5006 (21.7) 69 (0.30) 23,045 (100) M
dbSNP>HGMDe (No./%) 934 (92.9) 41 (4.08) 30 (2.99) 1005 (100) C
dbSNP>HapMap>HGMDf (No./%) 302 (91.0) 10 (3.01) 20 (6.02) 332 (100) Ch
ansSNP or missense mutation: variation expected to replace one amino acid (AA1) with a different amino acid (AA2)
btrSNP or nonsense mutation: variation expected to replace one amino acid (AA1) with a termination codon (TR)
csnSNP: variation expected not to change the original amino acid (AA1)
dVariation groups represented in Figure 1 diagram
eVariations concurrent in dbSNP and HGMD
fVariations concurrent in dbSNP, HapMap, and HGMD
doi:10.1371/journal.pone.0003575.t002
Coding Variations in Humans
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proportion of missense mutations predicted to be probably
damaging was almost twice that predicted to be possibly damaging
(49.7% vs 23.8%).
Assuming that the HapMap dataset mainly comprises non-
pathogenic variations (negative samples) and the HGMD dataset
comprises pathogenic variations (positive samples), we compared the
prediction performances of SIFT, PolyPhen, and PANTHER using
several criteria including sensitivity, specificity, positive predictive
value (p.p.v.), the Pearson correlation coefficient, and true-positive
cost. PANTHER showed the best prediction performance among
the three prediction programs. PANTHER surpassed SIFT in all
criteria and PolyPhen in specificity, p.p.v., and true-positive cost
(Table 5). PolyPhen surpassed SIFT in all criteria except for
specificity. PolyPhen was particularly superior to SIFT in sensitivity
(73.6% vs 65.2%, or 8.4%), which indicates that PolyPhen predicts
damaging CVs more accurately than SIFT. The difference in
specificity between SIFT and PolyPhen was 3.5%.
Figure 2. Distribution of amino acid change frequencies according to amino acid group (G1, nonpolar, aliphatic R group; G2,
aromatic R group; G3, polar, uncharged R group; G4, positively charged R group; and G5, negatively charged R group). Black vertical
bars indicate group [S-C] in dbSNP and gray vertical bars indicate group [M-C] in HGMD.
doi:10.1371/journal.pone.0003575.g002
Table 3. Comparison of variations according to type of
amino acid substitution.
nsSNPs in
dbSNP
Missense
mutations
in HGMD
Concurrent
variations
Substitution within the same
amino acid group
2232 (38.0%) 4534 (26.6%) 288 (30.8%)
Substitution between two
different amino acid groups
3643 (62.0%) 12,502 (73.4%) 646 (69.2%)
doi:10.1371/journal.pone.0003575.t003
Coding Variations in Humans
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Combination of the Prediction Programs
Predictions of the functional consequences of amino acid
substitutions can be made more accurate by combining different
in silico methods [15]. Thus, we combined prediction programs,
and found that this could significantly increase prediction
performance. Before combining the programs, we determined
the differences in the predictions of each program, since the
combination would be of no significant use if individual programs
produced identical predictions. Figure 3 shows a scatter plot of the
predicted scores of SIFT, PolyPhen, and PANTHER. Since a
lower SIFT or PANTHER score and a higher PolyPhen score
indicate that the variation of interest would be more deleterious, a
close distribution of the variation near the left lower corner
demonstrates agreement between the three programs on the
prediction. Missense mutations in CVM tended toward the left
lower corner (deleterious), while nsSNPs in CVH tended to be in
the right upper corner (tolerated). Even though HapMap and
HGMD tended to go in opposite directions, no significant
dependencies were observed in the distribution of prediction
scores by the three programs. The independence between the
predictions suggests a possibility that the combination of the
programs could improve the prediction performance.
To evaluate the combination approach, we regarded all of the
CVH data as negative and the CVM data as positive. We used the
SVMs of three different kernel functions in combining the three
programs. To train SVM, we randomly chose 281 of 563 (50%)
CVH from HapMap and 562 of 6282 (8.9%) CVM from HGMD
as a training dataset. The three kernels used for SVM training
were a linear kernel, a polynomial kernel, and a radial basis
function kernel. We evaluated the prediction performance of the
three models with the testing dataset. As shown in Figure 4, the
SVM combination outperformed the individual prediction pro-
grams. SVMpolynomial showed a slightly better prediction perfor-
mance in the region of high specificity than the other two SVM
combinations. PANTHER was superior to PolyPhen and SIFT in
terms of sensitivity over all specificity regions. SVMpolynomial
generally gave accurate and stable predictions compared to the
other combination approaches and the individual programs,
indicating that the appropriate combination can noticeably
improve the prediction accuracy.
Table 4. Predicted phenotypic effects of amino acid substitutions from three datasets by SIFT, PolyPhen, and PANTHER.
Datasets Prediction of phenotypic effect of amino acid substitutions
SIFT PolyPhen PANTHER
Tolerated Deleterious Benign
Possibly
damaging
Probably
damaging Tolerated Deleterious
nsSNPs in HapMap ([H-Ch]) 69.8%
(1005/1439)
30.2%
(434/1439)
66.3%
(811/1223)
19.1%
(234/1223)
14.6%
(178/1223)
72.2%
(782/1083)
27.8%
(301/1083)
nsSNPs in dbSNP ([S-C]) 63.7%
(2793/4387)
36.3%
(1594/4387)
63.1%
(2560/4056)
18.0%
(730/4056)
18.9%
(766/4056)
66.3%
(2290/3453)
33.7%
(1163/3453)
Missense mutations in HGMD
([M-C])
34.8%
(4516/12,995)
65.2%
(8479/12,995)
26.4%
(2922/11,049)
23.8%
(2635/11,049)
49.7%
(5492/11,049)
29.4%
(2727/9265)
70.6%
(6538/9265)
doi:10.1371/journal.pone.0003575.t004
Table 5. Comparison of the prediction performance of SIFT,
PolyPhen, and PANTHER.
Performance measure
criterion SIFT PolyPhen PANTHER
Sensitivity (%)a 65.2 73.6 70.6
Specificity (%)b 69.8 66.3 72.2
p.p.v. (%)c 95.1 95.2 95.6
Correlation coefficientd 2.31 3.12 2.70
True-positive coste 0.0512 0.0507 0.0460
aSensitivity = true positive/(true positive+false negative)
bSpecificity = true negative/(true negative+false positive)
cPositive predictive value = true positive/(true positive+false positive)
dCorrelation coefficient = (true positive6true positive2false positive6false
negative)/((true positive+false positive) (true positive+false negative) (true
negative+false positive)(true negative+false negative))1/2
eTrue-positive cost = false positive/true positive
doi:10.1371/journal.pone.0003575.t005
Figure 3. Scatter plot of predicted scores of SIFT, PolyPhen,
and PANTHER. Red triangles and blue circle plots indicate missense
mutations and nsSNPs, respectively. The ranges of predicted scores of
the three programs were different from each other (0–1 for SIFT, 0–4.6
for PolyPhen, and -13.4–1.1 for PANTHER). Lower SIFT or PANTHER
scores, or higher PolyPhen scores indicate that the predicted variant is
more deleterious. A close distribution in the left lower corner represents
an agreement of the three programs on deleterious effect.
doi:10.1371/journal.pone.0003575.g003
Coding Variations in Humans
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Discussion
In this study, we performed a genome-wide analysis of
variations in the coding sequence of the human genome in
different reference databases. CVM data from HGMD mainly
include CVs that are causative or highly penetrant for a particular
inherited disorder [23], while CVS from dbSNP and CVH from
HapMap mainly include CVs that are neutral or of low
penetrance. Therefore, CVs from different databases should show
different characteristics in several aspects such as amino acid
substitutions, protein function changes, and allele frequencies.
This is confirmed by the results of this analysis.
We observed that up to 8.11% of CVS in dbSNP are registered
as CVM in HGMD, and 4.36% of the CVM in HGMD are
registered as CVS in dbSNP. Among these concurrent CVs, there
were 41 truncation variations, 10 of which were also found in the
HapMap database. Some of the truncation CVs with low
validation scores (Figure S1) were found to be disease-causing
mutations. Heterozygosity information was available for 7
variations out of the 41. When we examined these seven
concurrent CVs, two of them appeared to be nonsense mutations.
The mutant alleles occurred in normal controls at relatively high
frequencies due to founder effects, for example, rs17602729 or
Gln12Term in the AMPD1 gene causing adenosine monophos-
phate deaminase deficiency [24], rs12948217 or Tyr231Term in
the ASPA gene causing Canavan diseases [25], and rs11571833 or
Lys3326Term in the BRCA2 gene causing hereditary breast and
ovarian syndrome. The remaining CVs include apparently
deleterious mutations at the molecular level, but their phenotypic
effects, i.e., disease association, should be interpreted with caution.
This is particularly the case for truncation CVs in the
pharmacogenetics genes and human leukocyte antigens (HLA)
(rs4986893 or Trp212Term in the CYP2C19 gene [26] and
rs1131156 or Ser14Term in the HLA-B gene [27]). Thirty snSNPs
were concurrent in HGMD, and 20 of them were also found in the
HapMap database. When we reviewed the references linked to
these 20 variations at HGMD, we found that most of them were
snSNPs and were registered in the HGMD database since they
were found to be associated with susceptibility mainly to common
complex diseases such as diabetes (see reference links in Table S1).
These observations indicate that some SNPs in dbSNP are truly
phenotypically mutational, and the interpretation of their
functional consequences should be based on the context of carriers
in the general population (or specific populations in case of
founder mutations), or in the context of the phenotypic impact of
the mutant molecule (for example, drug metabolism). In addition,
some truncation CVs need to be considered in the same context as
copy number variations, which have been recently reported to be
more common in the human genome than previously recognized
[28]. Some mutations in HGMD may be disease susceptibility
SNPs with low penetrance or in linkage to other risk alleles.
Although we examined the individual variations for these two
types of concurrent variations only, that is, truncation mutations
and snSNPs, our observations may be valid for at least some of the
amino acid-substituting variations in the human genome that
accounted for more than 90% of concurrent CVs. One of the best
examples is the factor V Leiden mutation in the F5 gene (R506Q,
rs6020), which is a founder mutation in Caucasian populations
[29]. The factor V Leiden mutation results in activated protein C
resistance at the molecular level and predisposes mutation carriers
to develop thrombotic diseases. Other examples include ABO
blood group variations.
In a particular set of 29 genes related to major cancer
predisposition syndromes, we also observed 141 concurrent CVs.
Among the 14 truncation variations concurrent in dbSNP and
HGMD, 10 occurred in the VHL gene. Von Hippel Lindau
syndrome is an autosomal dominant disease and thus one mutant
allele can cause the disease phenotype. To investigate the
variations of VHL in the general population, we resequenced
192 control chromosomes of Korean ethnic origin but found no
variation. Although we did not examine control chromosomes of
other ethnic origins, we believe that the truncation variations in
dbSNP of VHL are nonsense mutations.
Some genes with leader peptide sequences that are removed in
mature proteins have codon numbers based on the mature protein
in HGMD, rather than having the first Met as +1 according to the
recommendations by the Human Genome Variation Society
(http://www.hgvs.org/mutnomen/), for example, the coagulation
factor proteins such as F5. For these genes, one should take into
account the leader peptide sequences when examining the current
mutation database. Indeed, we could not match dbSNP and
HGMD for these genes because of their different codon
numbering, which explains why we could not find the aforemen-
tioned factor V Leiden mutation in our catalog of concurrent CVs.
In the distribution of amino acid substitutions, the most
remarkable difference between groups [S-C] and [M-C] was
observed in amino acid substitutions between the aromatic R
group (G2) and the polar, uncharged R group (G3). The
substitutions between G2 and G3 occurred in 8.8% of total
variations in group [M-C] and 3.9% in group [S-C]. The
substitution frequency agrees well with the chemical distance (CD)
from Grantham’s chemical difference matrix [30] (Table S4).
Relatively frequent substitutions in group [M-C] tend to have long
distances between amino acids, whereas relatively frequent
substitutions in group [S-C] tend to have short distances between
two amino acids. The substitution from cysteine (G2) to
phenylalanine (G3) occurred four times more frequently in group
[M-C] than in group [S-C], and the CD between cysteine and
phenylalanine was 205. For reference, the CDs of all amino acid
Figure 4. Receiver Operating Characteristic (ROC) curves of the
combination and individual predictors. The ROC curves of SVM
combination predictors tend toward the upper left corner of the plot
more than the three individual prediction programs. This suggests that
SVM combinations outperform the individual prediction programs.
SVMpolynomial showed a specificity of 75.9% and a sensitivity of 80.7%
when the threshold of SVM combination score was 0.8 (see Table 5).
doi:10.1371/journal.pone.0003575.g004
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pairs range from 5 to 215. The cysteine (G2)-to-tyrosine (G3)
substitution occurred ,10 times more often in group [M-C] than
in group [S-C], and the CD between cysteine and tyrosine was
also high (CD=194). The substitution between the most
chemically distant amino acid pair (cysteine [G2] and tryptophan
[G3]) occurred three times more often in group [M-C] than in
group [S-C]. Conversely, the substitution between isoleucine (G2)
and valine (G2) was observed three times more often in group [S-
C] than in group [M-C], and the CD between isoleucine and
valine is five. The threonine (G3)-to-serine (G3) substitution
occurred seven times more frequently in group [S-C] than in
group [M-C], and the CD between threonine and serine is 58.
Remarkablely, in all the amino acid groups, substitutions within
the same amino acid group were observed more frequently in
group [S-C] than in group [M-C] (38.0% vs 26.6%). Substitutions
within the same amino acid group accounted for 30.8% in the
concurrent CVs (group [C]), which fell between those in group [S-
C] and in group [M-C]. This observation suggests that the
concurrent CVs might be a mixture of SNPs and mutations,
supporting the hypothesis that some CVS in dbSNP are truly
phenotypic mutations, and some CVM in HGMD are disease-
susceptibility SNPs.
We used the SIFT, PolyPhen, and PANTHER programs to
predict the influence of thousands of amino acid-substituting CVs on
protein function. The three programs predicted 34–37% of the
nsSNPs in dbSNP and 28–34% of the nsSNPs in HapMap to be
deleterious or damaging. By other amino acid substitution programs,
approximately 25–30% of the putative nsSNPs cataloged in dbSNP
were predicted to negatively affect the protein function [15]. These
tend to be rare in the population. Among the nsSNPs in dbSNP
predicted to be deleterious, nsSNPs that are not in HapMap need to
be validated by experimental methods because they might be rare
variations that contribute to disease phenotypes.
A performance evaluation showed that PANTHER gave better
specificity, p.p.v., and true-positive cost than PolyPhen and SIFT,
while PolyPhen was better for sensitivity and correlation coefficient
than PANTHER and SIFT. In contrast, PANTHER produced
unpredicted results more often than the other two programs. The
non-prediction rate of PANTHER ranged from 41.2% to 45.8%,
the non-prediction rates of PolyPhen and SIFT ranged from
31.0% to 38.8% and 23.7% to 27.9%, respectively (PANTHER:
45.8% for group [H-Ch], 41.2% for group [S-C] and 45.6% for
group [M-C]; PolyPhen: 38.8% for group [H-Ch], 31.0% for
group [S-C] and 35.1% for group [M-C]; SIFT: 27.9% for group
[H-Ch], 25.3% for group [S-C] and 23.7% for group [M-C]). The
high non-prediction rate probably because PANTHER uses the
source of sequences and structures more strictly than PolyPhen
and SIFT and the reference data are not sufficient. The
insufficient prediction rate will be overcome as more information
is available [15]. It might be helpful to utilize a number of locus-
specific mutation databases for specific diseases or genes such as
the HbVar database [31] for human hemoglobin variations and
thalassemia mutations, and the IDR database [32] for immuno-
deficiency mutations.
Lastly, we could significantly increase the prediction power by
combining the programs, and we hypothesize that combining
more prediction programs may further improve the prediction
performance [16,17,20,22]. In the HGMD dataset, more missense
mutations were predicted to be deleterious by the SVMpolynomial
combination than nsSNPs from dbSNP. This result supports the
hypothesis that the functional prediction of CVs could distinguish
between missense mutations underlying Mendelian diseases and
functionally neutral nsSNPs [15]. In particular, the largest
proportion of CVs (326/461; 70.7%) in the concurrent group
[C] was predicted to be damaging (Table S5). This might include a
large fraction of medically detrimental mutations that are not
eliminated by purifying selection, possibly due to positive selection
or mutation-selection balance [33]. For variations in group [Ch],
the proportion of variations predicted to be damaging was high
(63/135; 46.7%), and the average allele frequency was relatively
low, compared to those predicted to be neutral (Figure S2). The T-
test result showed that the differences in allele frequencies between
the two variations for each population were significant (P,0.05).
We also found that some variations predicted to be damaging,
such as rs16941 and rs2020873, showed strong evidence for
positive selection (either an integrated haplotype score.2 or,22
[34]) (Table S5). Evidence of positive selection may be helpful in
identifying genetic variations associated with complex disease [35].
These results suggest that some concurrent variations predicted to
be damaging could be nsSNPs that affect protein function less
severely than missense mutations. Some common complex
diseases may be caused by a multitude of rare variations that
continue to exist because of an evolutionary mechanism [33].
In summary, this is the first study to look into human sequence
variations genome-wide in three representative reference databas-
es HGMD, dbSNP and HapMap. We found that a significant
proportion of CVs in HGMD and dbSNP overlap, and particular
caution is required in assessing these concurrent CVs with regard
to their phenotypic relevance. Bioinformatic analyses that employ
a combination of different algorithms can be helpful in
determining genotype-phenotype correlations by providing im-
proved functional predictions.
Materials and Methods
Reference Databases
We used three representative human sequence variation data-
bases: HGMD (http://www.hgmd.cf.ac.uk/ac/index.php; public
version January 2006), dbSNP (http://www.ncbi.nlm.nih.gov/
projects/SNP/; build 126), and HapMap (www.hapmap.org; NCBI
build 35). In general, ‘‘damaging and deleterious variations’’ indicate
variations underlying highly penetrant diseases, and ‘‘neutral or
susceptibility variations’’ indicate variations known to be phenotyp-
ically silent or associated with increased risk of developing a disease
[36]. The HapMap database is a subset of the dbSNP database and
is less likely to include pathogenic variants, since the HapMap data
were generated from randomly selected individuals.
Tools for Predicting Phenotypic Effects of Amino Acid
Substitution
We applied three representative in silico programs, SIFT [18],
PolyPhen [19], and PANTHER [21], to predict the phenotypic
effect of a CV amino acid substitution. The three programs use
different algorithms and thus may give a different prediction for
the same CV. As reference protein database, we used SWISS-
PROT for SIFT, PQS for PolyPhen, and PANTHER 6.1 for
PANTHER. To set up SIFT and PANTHER locally, we
downloaded SIFT (Linux version 2.1) from http://blocks.fhcrc.
org/sift/SIFT.html, PANTHER SNP scoring tool (Linux version
1.0) from http://www.pantherdb.org/downloads and SWISS-
PROT from ftp://ftp.ncbi.nih.gov/blast/db/FASTA. We execut-
ed PolyPhen online (http://genetics.bwh.harvard.edu/pph)
through batch processing, and have summarized the results.
Combination Analysis using SVM
By estimating the discriminant function, SVM classifies the data
into two classes [37]. It builds up a hyperplane as the decision
surface in a way that maximizes the margin of separation between
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positive and negative examples. Given a labeled set of M training
samples (Xi, Yi), where XiMRN and Yi is the associated label,
YiM21, 1, the discriminant hyperplane is defined by:
f (X )~
XM
i~1
Yiaik(X ,Xi)zb ð1Þ
where k(?,?) is a kernel function and the sign of f(X) determines the
membership of X. In our problem, Xi is a three-dimensional vector
(xi1, xi2, xi3) where xi1 is the SIFT score, xi2 is the PolyPhen score
and xi3 is the PANTHER subPSEC score of the variant of
interest, and Yi indicates the variant is positive (damaging CV) or
negative (neutral CV). Because the original prediction scores of
each program are on different scales (0–1 for SIFT, 0–4.6 for
PolyPhen, and 213.4–1.1 for PANTHER), we used the following
equation to make the score fall within the 0–1 range:
s(x)~
x{min(x)
max(x){min(x)
ð2Þ
where s(x) is a scaled score of an original prediction score x, and
min(x) and max(x) are the minimum and maximum values of x,
respectively.
We defined the SIFT and PANTHER scores as 1 minus their
scaled prediction value because a prediction value close to 0 means
a deleterious variant and a value close to 1 means a tolerant
variant. We used the SVMlight software package [38], which is
available at http://svmlight.joachims.org.
Supporting Information
Figure S1 Validation scores of concurrent variations (group [C])
according to variation type. Validation scores were obtained from
dbSNP. Horizontal bold lines show the average validation score.
The average validation score of nsSNPs (AA1.AA2) was 2.03, the
average of trSNPs (AA1.TR) was 1.27, and the average of
snSNPs (AA1.AA1) was 6.40 (see Table S1).
Found at: doi:10.1371/journal.pone.0003575.s001 (6.19 MB TIF)
Figure S2 Distribution of the variant allele frequency observed
in the three populations (CEU: Caucasian; ASN: Asian; and YRI:
African) in HapMap for variants in group [Ch] (for details, see
Table S5). The horizontal bold line in each population shows the
average variant allele frequency. For 63 variants predicted to be
damaging by the SVM combination, the average variant allele
frequency is relatively low (CEU: 0.09; ASN: 0.07; and YRI: 0.06),
compared to 72 variants predicted to be neutral by the SVM
combination (CEU: 0.15; ASN: 0.15; and YRI: 0.17). The
difference between the two variant groups was significant based
on the result of the t-test.
Found at: doi:10.1371/journal.pone.0003575.s002 (6.43 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0003575.s003 (0.51 MB
XLS)
Table S2
Found at: doi:10.1371/journal.pone.0003575.s004 (0.04 MB
DOC)
Table S3
Found at: doi:10.1371/journal.pone.0003575.s005 (0.09 MB
XLS)
Table S4
Found at: doi:10.1371/journal.pone.0003575.s006 (0.03 MB
XLS)
Table S5
Found at: doi:10.1371/journal.pone.0003575.s007 (0.31 MB
XLS)
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